Get started
Author

Adam Abdul Hakeem Baidoo

Observed names: Adam Baidoo, Baidoo, Adam Abdul Hakeem
ORCID: 0009-0003-1258-6766
Observed ORCID: 0009-0003-1258-6766
OpenAlex ID: A5046588499
Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
2023 · Suad Hannawi, Linda Saf Eldin, et al. · Nature Communications · 16
PDF
A comparison of EGFR mutation status in tissue and plasma cell-free DNA detected by ADx-ARMS in advanced lung adenocarcinoma patients
2019 · written on behalf of AME Lung Cancer Collaborative Group, Hanyan Xu, et al. · Translational Lung Cancer Research · 15
PDF
Immunogenicity and Safety of Omicron-Containing Multivalent COVID-19 Vaccines in Unvaccinated and Previously Vaccinated Adults
2024 · Suad Hannawi, Alaa Abuquta, et al. · Vaccines · 2
PDF
Comparative analysis of neutralization assays performed using live SARS-CoV-2 virus and pseudovirus to assess immunogenicity of a bivalent SARS-CoV-2 protein vaccine in humans
2025 · Cuige Gao, Jiang Yi, et al. · Frontiers in Immunology · 1
PDF
Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients
2025 · Felipe Dal-Pizzol, Suzana Margareth Lobo, et al. · Vaccines · 1
Baseline Anti-SARS-CoV-2 IgG and Protection from Symptomatic Infection: Post Hoc Analysis of the SCTV01E Phase 3 Randomized Trial
2025 · Lixin Yan, Jiang Yi, et al. · Vaccines
PDF
Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
2024 · Suad Hannawi, Linda Saf Eldin, et al. · Nature Communications
PDF
Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
2023 · Hannawi, Suad, Saifeldin, Linda, et al. · Figshare
Works count: 8
Citation count: 35
H-index: 2
I10-index: 2
Year
Topic
Type